Health
LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates – News-Medical.net
Iksuda Therapeutics today announced that it has expanded its research collaboration and License Agreement with LegoChem Biosciences,…
Iksuda Therapeutics, the developer of a new generation of antibody drug conjugates (ADCs) with raised therapeutic index, today announced that it has expanded its research collaboration and License Agreement with LegoChem Biosciences, Inc. (“LCB”) to explore…
Continue Reading
-
Noosa News12 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News13 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News7 hours agoArnie the dog found dead in stolen ute after week of searching
-
Noosa News6 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car